Initial Pharmacological Management of Newly Diagnosed Hypertension in the Elderly

First-Line Medication Selection

The European Society of Cardiology recommends starting with either a thiazide diuretic (hydrochlorothiazide 12.5 mg daily) or a calcium channel blocker (amlodipine 2.5-5 mg daily) as first-line monotherapy, using the lowest available dose and titrating gradually 1, 2
Thiazide diuretics (hydrochlorothiazide 12.5 mg daily) or dihydropyridine calcium channel blockers (amlodipine 2.5-5 mg daily) have the strongest evidence base from randomized controlled trials specifically in elderly patients with isolated systolic hypertension 1
ACE inhibitors (lisinopril 5-10 mg daily), angiotensin receptor blockers, and beta-blockers are also acceptable first-line options based on general guidelines, though trials specifically addressing isolated systolic hypertension primarily used thiazides and calcium antagonists 1

The American Heart Association recommends a goal of <140/90 mmHg if tolerated, same as younger patients 1
For patients ≥80 years old, a systolic BP of 140-145 mmHg is acceptable if <140 mmHg is not tolerated 2
Avoid excessive lowering of diastolic BP below 70-75 mmHg in patients with coronary heart disease to prevent reduced coronary perfusion 2

Most elderly patients require two or more drugs to achieve BP control, particularly to reach systolic BP <140 mmHg 1, 2
If BP remains uncontrolled after 4-6 weeks on monotherapy at appropriate doses, add a second agent from a different class 2
Preferred two-drug combinations include: thiazide + ACE inhibitor, thiazide + calcium antagonist, or ACE inhibitor + calcium antagonist 1

Always measure BP in both sitting and standing positions to detect orthostatic hypotension, which is more common in elderly patients 1
Reassess BP response within 4-6 weeks of starting or adjusting medication 2
Check for adverse effects including dizziness, falls, electrolyte disturbances, and renal function changes 1, 2

Do not withhold treatment in patients ≥80 years old based on age alone; the HYVET trial demonstrated 39% reduction in fatal stroke and 21% reduction in all-cause mortality with treatment in this age group 2
Do not start with high doses or escalate rapidly—this increases risk of hypotension, falls, and treatment discontinuation 1
Do not ignore orthostatic hypotension—always check standing BP as elderly patients are at higher risk 1
Do not assume hypertension is "adaptive" in very old adults—this outdated theory has been disproven 2

The American Heart Association recommends sodium restriction, weight reduction, DASH diet, increased physical activity, and alcohol moderation alongside medication 2
BP reductions with weight loss and sodium restriction are typically larger in elderly than younger adults 2
These interventions may reduce the number and dose of medications needed 2